Stalfort Sean

Insider CIK 1709418 · ABOS Director · VRCA Director · DOVA Director · TSHA Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
ABOS Acumen Pharmaceuticals, In	A Award deriv	2026-06-03	2026-06-05	53,250	—	$0	53,250	SEC↗
ABOS Acumen Pharmaceuticals, In	A Award	2026-06-03	2026-06-05	35,500	—	$0	220,624	SEC↗
TSHA Taysha Gene Therapies, Inc	A Award deriv	2026-06-01	2026-06-02	42,671	—	$0	42,671	SEC↗
TSHA Taysha Gene Therapies, Inc	A Award	2026-06-01	2026-06-02	21,335	—	$0	1,176,559	SEC↗
ABOS Acumen Pharmaceuticals, In	A Award deriv	2025-06-04	2025-06-05	19,500	—	$0	19,500	SEC↗
ABOS Acumen Pharmaceuticals, In	A Award	2025-06-04	2025-06-05	12,800	—	$0	185,124	SEC↗
TSHA Taysha Gene Therapies, Inc	A Award deriv	2025-06-02	2025-06-04	113,246	—	$0	113,246	SEC↗
TSHA Taysha Gene Therapies, Inc	A Award	2025-06-02	2025-06-04	56,623	—	$0	1,155,224	SEC↗
VRCA Verrica Pharmaceuticals In	G Gift	2024-11-26	2024-11-26	50,000	—	$0	1,873,800	SEC↗
VRCA Verrica Pharmaceuticals In	P Buy deriv	2024-11-22	2024-11-26	561,797	—	$0	561,797	SEC↗
VRCA Verrica Pharmaceuticals In	P Buy deriv	2024-11-22	2024-11-26	561,797	—	$0	561,797	SEC↗
VRCA Verrica Pharmaceuticals In	P Buy	2024-11-22	2024-11-26	1,123,595	—	$0	1,823,800	SEC↗
ABOS Acumen Pharmaceuticals, In	A Award deriv	2024-06-10	2024-06-10	25,000	—	$0	25,000	SEC↗
TSHA Taysha Gene Therapies, Inc	A Award deriv	2024-05-29	2024-05-31	98,440	—	$0	98,440	SEC↗
TSHA Taysha Gene Therapies, Inc	A Award	2024-05-29	2024-05-31	49,220	—	$0	1,098,601	SEC↗
TSHA Taysha Gene Therapies, Inc	G Gift	2023-08-16	2023-08-16	50,000	—	$0	1,049,381	SEC↗
TSHA Taysha Gene Therapies, Inc	P Buy	2023-08-16	2023-08-16	388,889	$0.90	$350.0K	999,381	SEC↗
TSHA Taysha Gene Therapies, Inc	P Buy	2023-08-16	2023-08-16	388,889	$0.90	$350.0K	884,290	SEC↗
TSHA Taysha Gene Therapies, Inc	A Award deriv	2023-06-22	2023-06-26	43,800	—	$0	43,800	SEC↗
ABOS Acumen Pharmaceuticals, In	A Award deriv	2023-06-06	2023-06-07	25,000	—	$0	25,000	SEC↗
VRCA Verrica Pharmaceuticals In	P Buy	2022-07-05	2022-07-05	238,095	$2.10	$500.0K	700,205	SEC↗
ABOS Acumen Pharmaceuticals, In	A Award deriv	2022-06-15	2022-06-17	25,000	—	$0	25,000	SEC↗
ABOS Acumen Pharmaceuticals, In	C Conversion deriv	2021-07-06	2021-07-08	130,180	—	$0	0	SEC↗
ABOS Acumen Pharmaceuticals, In	C Conversion deriv	2021-07-06	2021-07-08	131,595	—	$0	0	SEC↗
ABOS Acumen Pharmaceuticals, In	P Buy	2021-07-06	2021-07-08	35,000	$16.00	$560.0K	172,324	SEC↗
ABOS Acumen Pharmaceuticals, In	C Conversion	2021-07-06	2021-07-08	131,595	—	$0	131,595	SEC↗
ABOS Acumen Pharmaceuticals, In	C Conversion	2021-07-06	2021-07-08	130,180	—	$0	137,324	SEC↗
ABOS Acumen Pharmaceuticals, In	A Award deriv	2021-06-30	2021-07-02	34,000	—	$0	34,000	SEC↗
VRCA Verrica Pharmaceuticals In	P Buy	2020-08-14	2020-08-17	15,700	$6.38	$100.2K	462,110	SEC↗
VRCA Verrica Pharmaceuticals In	P Buy	2020-08-13	2020-08-17	15,550	$6.45	$100.3K	446,410	SEC↗
DOVA Dova Pharmaceuticals Inc.	U Tender	2019-11-12	2019-11-12	635,665	$27.50	$17.48M	0	SEC↗
VRCA Verrica Pharmaceuticals In	P Buy	2019-01-07	2019-01-07	8,021	$10.38	$83.3K	429,660	SEC↗
VRCA Verrica Pharmaceuticals In	P Buy	2019-01-07	2019-01-07	1,200	$10.94	$13.1K	430,860	SEC↗
DOVA Dova Pharmaceuticals Inc.	P Buy	2018-12-20	2018-12-21	31,000	$6.26	$194.1K	635,665	SEC↗
VRCA Verrica Pharmaceuticals In	C Conversion deriv	2018-06-19	2018-06-19	394,295	—	$0	0	SEC↗
VRCA Verrica Pharmaceuticals In	C Conversion	2018-06-19	2018-06-19	394,295	—	$0	421,639	SEC↗